MAPT and dementia: It has recently been demonstrated that in advanced dementia due to MAPT mutation, the regional [18F]AV‐1451 binding in vivo correlates strongly with the density of tau pathology post‐mortem, and with glucose hypometabolism,10 although differentiation between patients was not established, in either distribution or magnitude of [18F]AV‐1451 PET.